Browse Pet Safety Reports
16,709 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,709 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,709 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Dec 4, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Recovered/Normal |
| Dec 4, 2022 | Human | Unknown | Spinosad; Milbemycin Oxime | Rash; Itching | Outcome Unknown |
| Dec 3, 2022 | Human | Unknown | Praziquantel; Emodepside | Taste alteration; Tingling sensation; Unclassifiable adverse event | Outcome Unknown |
| Dec 1, 2022 | Human | Unknown | Ketoconazole | Nasal discharge; Nausea | Ongoing |
| Dec 1, 2022 | Human | Unknown | Tilmicosin | Shaking | Recovered/Normal |
| Nov 30, 2022 | Human | Unknown | Chlorhexidine Digluconate | Respiratory discomfort | Outcome Unknown |
| Nov 29, 2022 | Human | Unknown | Moxidectin | Injection site bruising; Swelling NOS; Skin sore; Accidental exposure | Outcome Unknown |
| Nov 28, 2022 | Human | Unknown | Moxidectin | Cellulitis; Injection site swelling; Accidental exposure | Outcome Unknown |
| Nov 28, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness | Recovered/Normal |
| Nov 27, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Tubes, Leaking; Accidental exposure | Recovered/Normal |
| Nov 25, 2022 | Human | Unknown | Tilmicosin | Heartburn; Accidental exposure; Bad taste | Outcome Unknown |
| Nov 25, 2022 | Human | Unknown | Selamectin;Sarolaner | Rash; Accidental exposure | Outcome Unknown |
| Nov 25, 2022 | Human | Unknown | Oclacitinib Maleate | Nausea; Accidental exposure | Recovered/Normal |
| Nov 23, 2022 | Human | Unknown | Buprenorphine | Dizziness; Vision blurred | Recovered/Normal |
| Nov 22, 2022 | Human | Unknown | Copper Naphthenate | Burning sensation (skin); Sinus congestion; Smell disorder NOS; Accidental ex... | Ongoing |
| Nov 22, 2022 | Human | Unknown | Oclacitinib Maleate | Infertility NOS | Outcome Unknown |
| Nov 22, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Accidental exposure | Outcome Unknown |
| Nov 16, 2022 | Human | Unknown | Selamectin;Sarolaner | Sneezing; Eye itching | Outcome Unknown |
| Nov 16, 2022 | Human | Unknown | Florfenicol; Mometasone Furoate; Terb... | Eye pain; Accidental exposure | Ongoing |
| Nov 15, 2022 | Human | Unknown | Tilmicosin | Puncture wound; Haemorrhage NOS; High blood pressure; Injection site pain | Outcome Unknown |
| Nov 14, 2022 | Human | Unknown | Buprenorphine | Skin irritation; Blistering (see also Application site SOC); Application site... | Ongoing |
| Nov 14, 2022 | Human | Unknown | Frunevetmab | Tingling sensation; Numbness; Puncture wound | Recovered/Normal |
| Nov 14, 2022 | Human | Unknown | Buprenorphine | Blistering (see also Application site SOC) | Recovered/Normal |
| Nov 14, 2022 | Human | Unknown | Buprenorphine | Visual field defect; Dizziness | Outcome Unknown |
| Nov 14, 2022 | Human | Unknown | Buprenorphine | Blistering (see also Application site SOC) | Ongoing |
| Nov 11, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Containers, Damaged; Containers, Leaking; Diffic... | Ongoing |
| Nov 9, 2022 | Human | Unknown | Buprenorphine | Rash | Recovered/Normal |
| Nov 9, 2022 | Human | Unknown | Clodronate Disodium | Puncture wound; Injection site tenderness; Injection site erythema; Medicatio... | Outcome Unknown |
| Nov 9, 2022 | Human | Unknown | Ivermectin | Reddening of the skin; Ocular discharge; Vision blurred; Drug administration ... | Outcome Unknown |
| Nov 9, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Medication error; Bad taste | Ongoing |
| Nov 7, 2022 | Human | Unknown | Chlorhexidine Digluconate | Eye redness; Containers, Leaking | Recovered/Normal |
| Nov 5, 2022 | Human | Unknown | Selamectin | Eye irritation; Accidental exposure | Outcome Unknown |
| Nov 5, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Medication error; Containers, Leaking; Product D... | Recovered/Normal |
| Nov 4, 2022 | Human | Unknown | Estriol Tablets | Medication error; Drowsiness - systemic disorder; Accidental exposure | Outcome Unknown |
| Nov 3, 2022 | Human | Unknown | Oclacitinib Maleate | No sign | Recovered/Normal |
| Nov 2, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Containers, Leaking; Tubes, Leaking; Accidental ... | Ongoing |
| Nov 2, 2022 | Human | Unknown | Melarsomine Dihydrochloride | Red eye; Eye inflamed; Eye itching; Lacrimation; Nausea; Puncture wound; Swol... | Outcome Unknown |
| Nov 2, 2022 | Human | Unknown | Ropinirole Hydrochloride | Vomiting; Malaise; Accidental exposure | Recovered/Normal |
| Nov 1, 2022 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Dry eye; Eye stinging | Outcome Unknown |
| Nov 1, 2022 | Human | Unknown | Buprenorphine | Dizziness; General illness | Outcome Unknown |
| Oct 29, 2022 | Human | Unknown | Selamectin | Hives (see also 'Skin'); Pruritus; Skin irritation; Dry skin | Ongoing |
| Oct 27, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site stickiness; Defect Unknown/Not Specified | Recovered/Normal |
| Oct 27, 2022 | Human | Unknown | Ceftiofur Crystalline Free Acid | Puncture wound; Accidental exposure | Outcome Unknown |
| Oct 26, 2022 | Human | Unknown | Ketoprofen;Tulathromycin | Puncture wound; Injection site swelling | Outcome Unknown |
| Oct 26, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site stickiness; Wrong technique in drug usage ... | Recovered/Normal |
| Oct 24, 2022 | Human | Unknown | Imidacloprid; Moxidectin | Light headedness; Stinging sensation in eye | Recovered/Normal |
| Oct 22, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site stickiness | Recovered/Normal |
| Oct 20, 2022 | Human | Unknown | Maropitant Citrate | Eye irritation | Recovered/Normal |
| Oct 20, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness; Medication error | Ongoing |
| Oct 19, 2022 | Human | Unknown | Selamectin | Itching | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.